University of Münster
CRIS@UM
DE | EN

Katrin Schlack

Current affiliations

  • Clinic for Urology

Publications

The Role of the Neutrophil to Lymphocyte Ratio for Survival Outcomes in Patients with Metastatic Castration-Resistant Prostate Cancer Treated with Abiraterone
Boegemann M, Schlack K, Thomes S, Steinestel J, Rahbar K, Semjonow A, Schrader AJ, Aringer M, Krabbe LM (2017)
In: ((Bitte Journal prüfen)), 18.
Research article (journal) | Peer reviewed | Published
The safety and efficacy of gemcitabine for the treatment of bladder cancer
Schlack K, Boegemann M, Steinestel J, Schrader AJ, Krabbe LM (2016)
In: ((Bitte Journal prüfen)), 16(3).
Research article (journal) | Peer reviewed | Published
The role of fPSA, [-2]proPSA and the Prostate Health Index for the early prediction of outcome in patients with metastatic castration resistant prostate cancer on therapy with abirateroneacetate.
Schlack K, Krabbe LM, Eminaga O, Semjonow A, Boegemann M (2016)
In: ASCO-GU, San Francisco. 
Abstract in digital collection (conference) | Published
Influence of Statins on Survival Outcome in Patients with Metastatic Castration Resistant Prostate Cancer Treated with Abiraterone Acetate
Boegemann M, Schlack K, Fischer AK, Gerß J, Steinestel J, Semjonow A, Schrader AJ, Krabbe LM (2016)
In: PloS one, 11.
Research article (journal) | Peer reviewed | Published
Early Prediction of Therapy Response to Abiraterone Acetate Using PSA Subforms in Patients with Castration Resistant Prostate Cancer
Schlack K, Krabbe LM, Fobker M, Schrader AJ, Semjonow A, Boegemann M (2016)
In: ((Bitte Journal prüfen)), 17.
Research article (journal) | Peer reviewed | Published
Show all publications